Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis.
Explore this paper's citation graph
Summary
Most prepubertal and pubertal patients with JIA had improved growth (DeltahSDS) in response to etanercept treatment when analyzed individually, and the need for intraarticular glucocorticoid injections was negatively correlated to the improved growth.
- Type
- article
- Published
- 2007-12-01
- Cited by
- 48
- References
- 0
- OpenAlex
- https://openalex.org/W1800685118
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:35168278
Keywords
Etanercept, Medicine, Internal medicine, Juvenile, Arthritis
References
No references recorded for this paper.
Cited by
- Juvenile idiopathic arthritis: an update for the clinician.
- Anti-TNF treatment in juvenile idiopathic arthritis and associated uveitis : Clinical perspectives on growth, uveitis, and drug survival
- Development of a paediatric musculoskeletal curriclum for medical students
- Juvenile Idiopathic Arthritis
- Effect of therapeutic interventions on skeletal growth & development in paediatric inflammatory bowel disease
- New treatment strategies for growth failure caused by chronic inflammation in children
- Biologic therapy and its effect on skeletal development in children with chronic inflammation
- Update on biologics in juvenile idiopathic arthritis
- Stress Response and Child Health
- Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases
- Effect of Biologic Treatments on Growth in Children with Juvenile Idiopathic Arthritis
- Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis
- Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives
- Challenges in the management of juvenile idiopathic arthritis with etanercept
- Secondary Osteoporosis in Patients with Juvenile Idiopathic Arthritis
- Treatment of juvenile idiopathic arthritis.
- Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis.
- The Effect of Acute and Chronic Stress on Growth
- Promoting Growth in Chronic Inflammatory Disease: Lessons from Studies of the Growth Plate
- The Biologics Anakinra and Etanercept Prevent Cytokine-Induced Growth Retardation in Cultured Fetal Rat Metatarsal Bones
Related papers
- Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.
- International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
- Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis
- Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
- Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
- Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.